Effects of Voglibose on Glycemic Excursions, Insulin Secretion, and Insulin Sensitivity in Non-lnsulin-ireated NIDDM Patients

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetes Care

• Publication date

  1998-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.21.2.256PMID 9539992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance

  1996cited by this paper
• Hyperinsulinemia as an independent risk factor for ischemic heart disease.

  1996cited by this paper
• The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.

  1996cited by this paper
• Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects.

  1996influential reference
• Does Suppression of Postprandial Blood Glucose Excursions by the α-Glucosidase Inhibitor Miglitol Improve Insulin Sensitivity in Diet-Treated Type II Diabetic Patients?

  1996cited by this paper
• Reduction of Glycosylated Hemoglobin and Postprandial Hyperglycemia by Acarbose in Patients With NIDDM: A placebo-controlled dose-comparison study

  1995cited by this paper
• 1,5-Anhydro-D-glucitol Evaluates Daily Glycemic Excursions in Well-Controlled NIDDM

  1995cited by this paper
• Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity.

  1994cited by this paper
• Differentiating Glucose Toxicity From Glucose Desensitization: A New Message From the Insulin Gene

  1994cited by this paper
• Insulin response after treatment depends on fasting plasma glucose level in NIDDM.

  1994cited by this paper
• Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients

  1994cited by this paper
• Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function

  1993cited by this paper
• Effect of an intestinal disaccharidase inhibitor (AO-128) on obesity and diabetes.

  1992cited by this paper
• Glucose Toxicity

  1990cited by this paper
• Combination Insulin-Sulfonylurea Therapy

  1990cited by this paper
• Effect of Acarbose on Carbohydrate and Lipid Metabolism in NIDDM Patients Poorly Controlled by Sulfonylureas

  1990cited by this paper
• Coupling of β-Cell Desensitization by Hyperglycemia to Excessive Stimulation and Circulating Insulin in Glucose-Infused Rats

  1990cited by this paper
• Effects of 8-Wk α-Glucosidase Inhibition on Metabolic Control, C-Peptide Secretion, Hepatic Glucose Output, and Peripheral Insulin Sensitivity in Poorly Controlled Type II Diabetic Patients

  1989cited by this paper
• Synthesis and alpha-D-glucosidase inhibitory activity of N-substituted valiolamine derivatives as potential oral antidiabetic agents.

  1986cited by this paper
• In vitro exhaustion of pancreatic beta-cells.

  1986cited by this paper
• Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population

  1980cited by this paper
• THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.

  1965cited by this paper
• [M-VALUE, AN INDEX FOR BLOOD SUGAR CONTROL IN DIABETICS].

  1964cited by this paper

• Alpha-Glucosidase Inhibitors in Aging and Aging-Related Diseases: Clinical Applications and Relevant Mechanisms

  2024cites this paper
• The effect of voglibose on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials.

  2020cites this paper
• Comparison of Glycemic Excursion Using Flash Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Before and After Treatment with Voglibose

  2020cites this paper
• Mechanism of non-enzymatic antiglycation action by coumarin: a biophysical study

  2019cites this paper
• Voglibose-mediated alterations in neurometabolomic profiles in the hypothalamus of high-fat diet-fed mice

  2019cites this paper
• Chain-Branched Polyhydroxylated Octahydro-1H-Indoles as Potential Leads against Lysosomal Storage Diseases

  2019cites this paper
• Streptomyces species: Ideal chassis for natural product discovery and overproduction.

  2018cites this paper
• Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

  2018cites this paper
• Glycemic Pentad Glycemic Pentad Forum

  2017cites this paper
• Voglibose: An Important Drug for Type 2 Diabetes

  2017cites this paper
• Elimination of indigenous linear plasmids in Streptomyces hygroscopicus var. jinggangensis and Streptomyces sp. FR008 to increase validamycin A and candicidin productivities

  2017cites this paper
• Beneficial effects of voglibose administration on body weight and lipid metabolism via gastrointestinal bile acid modification.

  2016cites this paper
• Potential Dual Role of Eugenol in Inhibiting Advanced Glycation End Products in Diabetes: Proteomic and Mechanistic Insights

  2016cites this paper
• Agranulocytosis due to an α-glucosidase inhibitor, voglibose

  2015cites this paper
• IMPAIRED GLUCOSE TOLERANCE AND ROLE OF VOGLIBOSE : AN OBSERVATIONAL STUDY

  2015cites this paper
• Potential antidiabetic activity of naturally occurring compounds by enzyme α-glucosidase inhibition

  2015cites this paper
• Positive and negative regulation of GlnR in validamycin A biosynthesis by binding to different loci in promoter region

  2015cites this paper
• Engineering validamycin production by tandem deletion of γ-butyrolactone receptor genes in Streptomyces hygroscopicus 5008.

  2015cites this paper
• Role of voglibose in prevention of type 2 diabetes in established case of impaired glucose tolerance: an observation study

  2015cites this paper
• Postprandial Glycemic Control Conditions in Relation to Urinary N-Acetyl-β-d-Glucosaminidase in Patients with Type 2 Diabetes Mellitus Without Low Glomerular Filtration Rate

  2014cites this paper
• Sympathetic nerve activity in type 2 diabetes mellitus; a promising potential therapeutic target

  2014cites this paper
• Voglibose administration regulates body weight and energy intake in high fat-induced obese mice.

  2014cites this paper
• Comparison of effects of α-Glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease.

  2014cites this paper
• DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

  2014influential citation
• 血糖変動指標としての1,5-AG測定の有用性と治療効果判定への応用

  2014cites this paper
• Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus.

  2014cites this paper
• Efficacy of voglibose in type 2 diabetes

  2014cites this paper
• Новые терапевтические возможности в лечении сахарного диабета 2-го типа: добавление к лираглутиду инсулина детемир

  2013cites this paper
• Exogenous 1,4‐butyrolactone stimulates A‐factor‐like cascade and validamycin biosynthesis in Streptomyces hygroscopicus 5008

  2013cites this paper
• Relationship between postprandial glucose level and carotid artery stiffness in patients without diabetes or cardiovascular disease

  2013cites this paper
• Inhibitory effect of components from Streptomyces species on α-glucosidase and α-amilase of different origin

  2013cites this paper
• The vascular endothelium in diabetes—a therapeutic target?

  2013cites this paper
• The importance of synthetic drugs for type 2 diabetes drug discovery

  2013cites this paper
• Alogliptin, but not voglibose, ameliorates dyslipidemia and LDL particle size in patients with impaired glucose tolerance or Type 2 diabetes

  2013cites this paper
• Effects of voglibose and nateglinide on glycemic status and coronary atherosclerosis in early-stage diabetic patients.

  2012cites this paper
• Urinary N‐acetyl‐β‐d‐Glucosaminidase Levels are Positively Correlated With 2‐Hr Plasma Glucose Levels During Oral Glucose Tolerance Testing in Prediabetes

  2012cites this paper
• Is There a Role for α-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

  2012cites this paper
• Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator‐controlled, double‐blind study

  2012cites this paper
• Genomic and transcriptomic insights into the thermo-regulated biosynthesis of validamycin in Streptomyces hygroscopicus 5008

  2012cites this paper
• Effects of sex and age on serum 1,5-anhydroglucitol in nondiabetic subjects.

  2012cites this paper
• Rapid identification of the α-glucosidase inhibitory compounds from Thunberg’s Geranium (Geranium thunbergii Sieb. et Zucc.)

  2012influential citation
• Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes

  2011cites this paper
• Anti-Diabetic Effects of Actinidia arguta Polyphenols on Rats and KK-Ay Mice

  2011cites this paper
• Over-expression of UDP-glucose pyrophosphorylase increases validamycin A but decreases validoxylamine A production in Streptomyces hygroscopicus var. jinggangensis 5008.

  2011cites this paper
• Design, Synthesis, Molecular Docking and Crystal Structure Prediction of New Azasugar Analogues of α‐Glucosidase Inhibitors

  2011cites this paper
• Effect of pioglitazone on muscle sympathetic nerve activity in type 2 diabetes mellitus with α-glucosidase inhibitor.

  2010cites this paper
• Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

  2009cites this paper
• Treatment Of Insulin Resistance

  2009cites this paper
• 1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions

  2008cites this paper
• Effects of a late evening snack combined with α‐glucosidase inhibitor on liver cirrhosis

  2008cites this paper
• Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet.

  2008cites this paper
• Studies directed toward the stereochemical structure determination of the naturally occurring glucosidase inhibitor, kotalanol: synthesis and inhibitory activities against human maltase glucoamylase of seven-carbon, chain-extended homologues of salacinol.

  2008cites this paper
• Polyhydroxylated indolines and oxindoles from C-glycosides via sequential Henry reaction, Michael addition, and reductive amination/amidation.

  2007cites this paper
• Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice.

  2006cites this paper
• REPEATED EPISODES OF PARALYTIC ILEUS IN AN ELDERLY DIABETIC PATIENT TREATED WITH VOGLIBOSE

  2006cites this paper
• Relation between Cerebral Arterial Pulsatility and Insulin Resistance in Type 2 Diabetic Patients

  2006cites this paper
• Decreased insulin sensitivity is associated with the extent of coronary artery disease in patients with angina

  2005cites this paper
• Aging per se does not influence postprandial glucose levels in type 2 diabetes

  2005cites this paper
• Synthesis and glycosidase inhibitory activity of new penta-substituted C8-glycomimetics

  2005cites this paper
• Different effects of two alpha-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) level.

  2004cites this paper
• The effects of oral anti‐hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes

  2004cites this paper
• [Effects of the flavonoid fraction from Ginkgo biloba extract on the postprandial blood glucose elevation in rats].

  2004cites this paper
• Effect of a Hot-water Extract from Coffee Beans on the Postprandial Blood Glucose Concentration in Rats

  2004cites this paper
• Synthesis of C8-glycomimetics as potential glycosidases inhibitors

  2004cites this paper
• 2型糖尿病における高感度C-reactive protein高値の意義

  2003cites this paper
• Usefulness of troglitazone administration to obese hyperglycaemic patients with near‐normoglycaemia

  2003cites this paper
• Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus.

  2003cites this paper
• Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

  2003cites this paper
• Synthesis and glycosidase inhibitory activity of enantiopure polyhydroxylated octahydroindoles and decahydroquinolines, analogs to castanospermine

  2003cites this paper
• Synthesis and glycosidase inhibitory activity of aminocyclitols with a C6- or a C7-ring

  2003cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Insulin-lowering agents in the management of polycystic ovary syndrome.

  2003cites this paper
• Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients.

  2002cites this paper
• Effect Of Kad‐1229, A Novel Hypoglycaemic Agent, On Plasma Glucose Levels After Meal Load In Type 2 Diabetic Rats

  2002cites this paper
• Insulin Sensitivity is Associated with the Presence and Extent of Coronary Artery Disease

  2002cites this paper
• Combination therapy of alpha-glucosidase inhibitor and a sulfonylurea compound prolongs the duration of good glycemic control.

  2002cites this paper
• Dietary fiber and glucose metabolism and diabetes

  2001cites this paper
• Correction of hyperglycaemia reduces insulin resistance and serum soluble E‐selectin levels in patients with Type 2 diabetes mellitus

  2001cites this paper
• Post-load glucose measurements in oral glucose tolerance tests correlate well with 1,5-anhydroglucitol, an indicator of overall glycaemic state, in subjects with impaired glucose tolerance.

  2001cites this paper
• Current therapies and emerging targets for the treatment of diabetes.

  2001cites this paper
• Insulin resistance and coronary risk factors in Japanese type 2 diabetic patients with definite coronary artery disease.

  2001cites this paper
• Characteristics of type 2 diabetic patients responding to voglibose administration as an adjunct to sulfonylurea.

  2001cites this paper
• The influence of traditional Chinese herbal drugs on serum 1, 5-anhydroglucitol levels.

  2000cites this paper
• Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia

  2000cites this paper
• Pharmacotherapy of Type 2 Diabetes Mellitus

  2000cites this paper
• Pathophysiology and pharmacological treatment of insulin resistance.

  2000cites this paper
• [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors].

  1999cites this paper
• Actualités dans les traitements du diabète de type 2. Les inhibiteurs des alpha-glucosidases

  1999cites this paper
• Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes.

  1999cites this paper
• Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke.

  1999cites this paper
• Lack of kinetic interaction between digoxin and voglibose

  1999cites this paper
• Traitements oraux du diabète

  1999cites this paper
• A Simple Device for Foot Pressure Measurement: Evaluation in South Indian NIDDM subjects

  1998cites this paper
• The Efficacy of Voglibose on Glycemic Excursions in Non-Insulin-Treated NIDDM Patients

  1998cites this paper
• “ Nano Pharmaceutical for diabetes Management using plant Extract..”

  year unknowncites this paper